Dr Johan Vande Voorde

  • Senior Research Fellow (Therapeutic Science Research)

telephone: 01413304211
email: Johan.VandeVoorde@glasgow.ac.uk

Import to contacts




Dr Johan Vande Voorde obtained his PhD in the laboratory of Jan Balzarini (KU Leuven, Belgium) where he studied the impact of tumour-associated bacteria on chemotherapy. In 2015, he joined Eyal Gottlieb’s group at the CRUK Scotland Institute (formerly CRUK Beatson Institute). There, he studied metabolic vulnerabilities of colorectal cancer and the metabolic effects of Plasmax, a cell culture medium that more closely mimics physiology. In 2018, he joined the team of Owen Sansom, director of the CRUK Scotland Institute, as part of Cancer Grand Challenges Team Rosetta. Within this multidisciplinary consortium, he applied metabolic profiling of colorectal cancer for tissue stratification and target discovery.

Johan set up his independent research group at the University of Glasgow in 2024, funded by a CRUK Career Development Fellowship and a Lord Kelvin/Adam Smith Leadership Fellowship. His laboratory studies cancer metabolism and the role of the gut microbiome in cancer.

Research interests

The Vande Voorde lab studies metabolic rewiring in cancer. We have a particular interest in how the gut microbiome shapes metabolite availability, and the effects of microbiota on cancer progression and therapy response. In addition, we study the systemic consequences of cancer-related metabolic perturbations (e.g. muscle wasting).


  • Cancer Research UK Career Development Fellowship (2024-2030)
  • Lord Kelvin / Adam Smith Leadership Fellowship (2024-2030)
  • Senior Research Fellowship (University of Glasgow, 2024-2028)
  • Pancreatic Cancer UK Research Innovation Fund (2022-2023)